Plant viruses are infectious agents that specifically target plants, causing diseases that can impact crop yields, quality, and overall agricultural productivity. These viruses are typically composed of genetic material (RNA or DNA) enclosed in a protein coat, and they rely on plant cells for replication and spread. Transmission of plant viruses can occur through various vectors, such as insects, nematodes, or even human activities like seed transmission. Once infected, plants may exhibit symptoms like yellowing, stunting, leaf curling, and mosaic patterns. Plant viruses pose significant challenges to agriculture, leading to economic losses and affecting food security. Common plant viruses include Tobacco mosaic virus, Tomato mosaic virus, and Potato virus Y. Control strategies for plant viruses involve integrated pest management, breeding resistant crop varieties, and, in some cases, the use of antiviral chemicals. Ongoing research in plant virology aims to understand virus-host interactions, develop sustainable management practices, and explore novel technologies for virus control in agriculture.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States